Skip to main content

Year: 2025

Stella-Jones Completes Acquisition of Brooks Manufacturing Co.

MONTREAL, Nov. 05, 2025 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced that it has completed the previously announced acquisition of the assets of Brooks Manufacturing Co. (“Brooks”). The purchase price amounted to approximately US$140 million, subject to working capital adjustments. Brooks manufactures treated wood distribution crossarms and transmission framing components from their facility located in Bellingham, Washington. Brooks’ consolidated sales for the year ended December 31, 2024 totaled approximately US$84 million. “We are pleased to officially welcome the Brooks team to Stella-Jones,” stated Eric Vachon, President and Chief Executive Officer of Stella-Jones. “This acquisition further strengthens our position as a partner of choice to utilities and aligns with our ambitions...

Continue reading

Brookfield Renewable Reports Third Quarter Results

All amounts in U.S. dollars unless otherwise indicated BROOKFIELD, News, Nov. 05, 2025 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) (“Brookfield Renewable Partners”, “BEP“) today reported financial results for the three and nine months ended September 30, 2025. “We had another strong quarter, advancing several strategic priorities while delivering strong financial results. In October, we announced a transformational partnership with the U.S. Government that should significantly accelerate deployment of Westinghouse’s leading reactor technology in the U.S. and abroad, which we expect to drive substantial growth for our business for years to come,” said Connor Teskey, CEO of Brookfield Renewable.  He continued, “We continued to extend our leadership position in essential baseload power...

Continue reading

Fortrea Reports Third Quarter 2025 Results

For the three months ended September 30, 2025, from continuing operations:Revenues of $701.3 million GAAP net loss of $(15.9) million Adjusted EBITDA of $50.7 million GAAP and adjusted net (loss) income per diluted share of $(0.17) and $0.12, respectively Book-to-bill ratio of 1.13x, resulting in 1.07x book-to-bill for the trailing 12 months Cost saving initiatives remain on track Raising 2025 revenue guidance to a range of $2,700 million to $2,750 million; narrowing 2025 adjusted EBITDA guidance to a range of $175 million to $195 millionDURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the third quarter ended September 30, 2025. “Fortrea delivered a solid performance that met expectations in the...

Continue reading

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ETPhase 2/3 OCU410ST GARDian3 pivotal confirmatory trial is progressing toward 1H 2027 Biologics License Application (BLA) filing with 50% enrollment completed to dateEuropean Medicines Agency (EMA) provided acceptability of a single U.S.-based trial for submission of a Marketing Authorization Application (MAA)Executed licensing agreement with Kwangdong Pharmaceutical for exclusive rights in South Korea to OCU400Sales milestones of $1.5 million for every $15 million of sales in South Korea, projected to reach $180 million or more in first 10 years of commercialization and royalties equaling 25% of net salesClosed $20 million registered direct offering of common stock and accompanying premium warrantsThe Company will receive $30 million of additional gross proceeds if the warrants...

Continue reading

Parsons Reports Third Quarter 2025 Results

Q3 2025 Financial Highlights Q3 revenue of $1.6 billion decreased 10% year-over-year and 14% on an organic basis Revenue growth of 14% excluding confidential contract; 9% on an organic basis Q3 net income of $64 million decreased $8 million year-over-year Q3 adjusted EBITDA decreased 5% to $158 million; adjusted EBITDA margin of 9.8% increased 60 basis points Book-to-bill ratio of 1.0x and continued streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since IPO Total backlog increased to $8.8 billion; 72% is funded, highest level since IPO Modifying fiscal year 2025 revenue and reiterating adjusted EBITDA and cash flow guidance ranges at mid-pointCHANTILLY, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) today announced financial results for the third quarter ended September 30, 2025. CEO...

Continue reading

Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map designed to accelerate treatments for a wide range of neurological diseases With this achievement, Recursion will have reached over $500 million in milestone and upfront payments across all its partnerships and collaborations Approximately $785 million of cash and cash equivalents (unaudited) as of October 9, 2025- runway through the end of 2027, without additional financingSALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its third quarter ended September 30, 2025. Recursion will host a (L)earnings Call on November 5, 2025...

Continue reading

Golar LNG Limited Interim results for the period ended September 30, 2025

Highlights and subsequent eventsGolar LNG Limited (“Golar” or “the Company”) reports Q3 2025 net income attributable to Golar of $31 million, Adjusted EBITDA1 of $83 million and Total Golar Cash1 of $661 million, before bond offering proceeds in October 2025.Entered the U.S. rated bond market with $500 million of 5-year 7.5% senior unsecured notes (the “Notes”) on October 2, 2025.Repaid $190 million outstanding principal balance of the $300 million 2025 maturing 2021 Unsecured Bonds on October 20, 2025.Gimi operations normalize following post-COD equipment tuning. Daily production is now frequently exceeding base capacity.Seatrium shipyard selected for FLNG Hilli (“Hilli”) re-deployment scope between current contract in Cameroon and commencement of her 20-year contract in Argentina.Final Investment Decision (“FID”) and...

Continue reading

T1 Energy Reschedules Third Quarter 2025 Earnings Release and Conference Call

AUSTIN, Texas and NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) announced this morning that the Company has rescheduled its third quarter earnings release and conference call to November 14, 2025. The third quarter 2025 press release will be issued at or around 6:00 am Eastern Daylight Time. The conference call is scheduled to begin at 8:00 am Eastern Standard Time. To access the conference call, listeners should proceed as follows:Click on the call link and complete the online registration form. Upon registering, you will receive dial-in information and a unique PIN to join the call as well as an email confirmation with details. Select a method for joining the call:Dial in: A dial in number and unique PIN are displayed to connect directly by phone. Call Me: Enter...

Continue reading

MRC Global Announces Third Quarter 2025 Results 

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC) today announced third quarter 2025 results from continuing operations. Third Quarter 2025 Financial Highlights:Sales of $678 million, a 15% decrease compared to the second quarter of 2025 Gross profit, as a percentage of sales, of 18.4% Adjusted Gross Profit, as a percentage of sales, of 21.8% Net loss from continuing operations of $9 million Adjusted EBITDA of $36 million, or 5.3% of sales Revenue backlog of $571 million, an increase of 4% compared to the same period last year (a 21% year-on-year increase in the U.S. segment backlog)Rob Saltiel, MRC Global’s President and CEO, commented, “The implementation of our new enterprise resource planning (ERP) system in our U.S. segment encountered significant challenges that adversely impacted our revenues, profitability,...

Continue reading

Brilliant Earth Reports Strong Q3 Results Exceeding High End of Net Sales Guidance and 17th Consecutive Quarter of Positive Adjusted EBITDA

Delivered Y/Y Net Sales Growth of 10.4%Drove Y/Y Bookings Growth in Engagement RingsAchieved 45% Y/Y Bookings Growth in Fine JewelryDelivered 57.6% Gross Margin SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced financial results for the three and nine months ended September 30, 2025. Third Quarter 2025 Highlights (quarterly period ended September 30, 2025):Delivered Third Quarter Net Sales of $110.3 million, a 10% year-over-year growth, exceeding the Company’s guidance rangeAchieved a return to year-over-year bookings growth in engagement rings with an increase in ASP quarter over quarter Delivered highest-ever wedding and anniversary band bookings with double-digit...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.